let's wait and see how would the annual report do to this stock in July On the webinar, JK said AT1 has already close to double its revenue (30/4) compare to FY19 and this does not include anything related to COVID-19. AT1 has already sold 1.3 million devices to NG till now and many more to come. If AT1 gets a deal with a US company,(JK said he's in discussion with 2 US companies) that would be huge, given there's already FDA approval for the COVID antibody test to another company.
AT1 Price at posting:
37.0¢ Sentiment: Hold Disclosure: Held
